PROGNOSTIC VALUE OF CHILD-PUGH, MELD, AND MELDNA SCORES IN PATIENTS WITH DECOMPESATED HEPATITIS B CIRRHOSIS

Văn Tuấn Nguyễn , Thị Diệu Ngân Tạ

Main Article Content

Abstract

To evaluate the prognostic value of the Child-Pugh, MELD, and MELDNa scores in patients with decompensated hepatitis B cirrhosis, we conducted a study in 149 patients with decompensated hepatitis B cirrhosis treated at the National hospital for Tropical diseases from August 2022 to July 2023. The patients were followed and mortality was evaluated within 90 days after admission. The study results showed that the mortality rates was 32.2%, respectively. The main causes of death were hepatic encephalopathy (58,3%), followed by gastrointestinal bleeding (20.8%), and infection (8.3%). The proportions of Child-Pugh class B and C were 45.6% and 47.7%, respectively; the group with MELD scores > 18 points accounted for 76.5%; the MELDNa groups with scores of 20-29 and 30-39 accounted for 40.3% and 36.9%, respectively. MELDNa had a better predictive value for mortality compared to MELD and Child-Pugh, with area under the curve (AUC) values of 0.732, 0.655, and 0.578, respectively. The optimal cutoff points for Child-Pugh, MELD, and MELDNa in predicting mortality were 8, 23, and 25, with sensitivities/specificities of 81.3%/37.6%; 68.8%/49.5% and 87.5%/47.5%, respectively.

Article Details

References

1. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-266.
2. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44(1):217-231.
3. Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study. Liver Int Off J Int Assoc Study Liver. 2006;26(7):834-839.
4. Pagliaro L. MELD: the end of Child-Pugh classification? J Hepatol. 2002;36(1):141-142.
5. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-460.
6. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị bệnh viêm gan virus B (Ban hành kèm quyết định số 3310/QĐ-BYT ngày 29/07/2019 của Bộ Y tế. Published online 2019.
7. Nababan SHH, Mansjoer A, Fauzi A, Gani RA. Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia. BMC Gastroenterol. 2021;21(1):392.
8. Lê Thị Lan. Đặc điểm lâm sàng và các yếu tố liên quan đến suy gan cấp ở bệnh nhân xơ gan mất bù do viêm gan virus B tại Bệnh viện Nhiệt đới Trung ương. Luận Văn Thạc Sĩ Học - Trường Đại Học Y Hà Nội. Published online 2021.
9. Nguyễn Thị Kim Chính. Đặc điểm lâm sàng và xét nghiệm trong viêm gan mạn và xơ gan sau viêm gan virus B có HBeAg âm tính và HBeAg dương tính. Luận Văn Bác Sỹ Chuyên Khoa Cấp II - Trường Đại Học Hà Nội. Published online 2007.
10. Vicco MH, Rodeles L, Ferini F, Long AK, Musacchio HM. In-hospital mortality risk factors in patients with ascites due to cirrhosis. Rev Assoc Médica Bras. 2015;61(1):35-39.